MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,517,464 | -9.5% | 108,605 | -9.3% | 0.01% | -10.0% |
| Q1 2023 | $2,782,002 | +60.1% | 119,759 | 0.0% | 0.01% | +42.9% |
| Q4 2022 | $1,737,703 | -9.0% | 119,759 | +19.6% | 0.01% | -12.5% |
| Q3 2022 | $1,910,000 | +5.0% | 100,094 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $1,819,000 | -27.9% | 100,094 | 0.0% | 0.01% | -12.5% |
| Q1 2022 | $2,522,000 | -8.7% | 100,094 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $2,763,000 | +10.1% | 100,094 | +28.8% | 0.01% | 0.0% |
| Q3 2021 | $2,509,000 | -9.8% | 77,688 | -14.6% | 0.01% | -11.1% |
| Q2 2021 | $2,781,000 | +7.3% | 90,941 | +6.9% | 0.01% | 0.0% |
| Q1 2021 | $2,591,000 | +72.7% | 85,096 | -35.7% | 0.01% | +50.0% |
| Q2 2020 | $1,500,000 | +12.1% | 132,244 | +41.4% | 0.01% | 0.0% |
| Q1 2020 | $1,338,000 | -47.4% | 93,499 | 0.0% | 0.01% | -40.0% |
| Q4 2019 | $2,546,000 | -0.5% | 93,499 | +4.6% | 0.01% | 0.0% |
| Q3 2019 | $2,560,000 | – | 89,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |